Benchmarking AlphaMissense Pathogenicity Predictions Against Cystic Fibrosis Variants.

ABSTRACT: Variants in the cystic fibrosis transmembrane conductance regulator gene (CFTR) result in cystic fibrosis - a lethal autosomal recessive disorder. Missense variants that alter a single amino acid in the CFTR protein are among the most common cystic fibrosis variants, yet tools for accurately predicting molecular consequences of missense variants have been limited to date. AlphaMissense (AM) is a new technology that predicts the pathogenicity of missense variants based on dual learned protein structure and evolutionary features. Here, we evaluated the ability of AM to predict the pathogenicity of CFTR missense variants. AM predicted a high pathogenicity for CFTR residues overall, resulting in a high false positive rate and fair classification performance on CF variants from the CFTR2

SUBMITTER: McDonald EF 

PROVIDER: S-EPMC10592606 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature